Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

Condition:   Healthy Volunteers Interventions:   Drug: 30 mg dexlansoprazole capsules manufactured at TOB;   Drug: 30 mg dexlansoprazole capsules manufactured at TPC;   Drug: 60 mg dexlansoprazole capsules manufactured at TOB;   Drug: 60 mg dexlansoprazole capsules manufactured at TPC Sponsor:   Takeda Recruiting - verified April 2017

Source: ClinicalTrials.gov - April 24, 2017 Category: Research Source Type: clinical trials